MDS Professional Report

This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.

The explosion of information on MDS forces us to seek novel, alternative ways to distribute it. Podcasts gives us an easy and popular way to communicate this information in a short time.

Season 2
- Welcome to season 2 of the MDS Professional Report. We look forward to your feedback!
  Episode 1:
  
  MDS in ASH 2021 – Are We Already in the Molecular Era?
  
  Dr. Moshe Mittelman and Dr. Drorit Merkel
  
  Drs. Moshe Mittelman, of The Tel Aviv Sourasky Medical Center, and Drorit Merkel, of the Sheba Medical Center, both from Tel Aviv University, Israel, discuss several important presentations from the recent 2021 ASH meeting.
  
  Learn More and Listen

MDS Professional Report

This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.

MDS in ASH 2021 – Are We Already in the Molecular Era?

Dr. Moshe Mittelman and Dr. Drorit Merkel

TP53 Mutations: Were They Born Equal?

Moshe Mittelman, MD

Don’t Withhold Anti-Neoplastic Treatment from your Hematological Patients Infected by COVID

Moshe Mittelman, MD

Will Venetoclax Become The New Standard?

Dr. Galia Stemer & Dr. Moshe Mittelman

Do Immune Check Inhibitors have a Role in the Treatment of Higher-Risk MDS?

Dr. Howard S. Oster

Thank you to Bristol-Myers Squibb and Gamida Cell for supporting this initiative.

CONTACT US

MEMBER OF